The role of biomarkers in the management of patients with lymphoma: Promise versus reality

HsiE.

首页> 外文期刊>Clinical lymphoma & myeloma >The role of biomarkers in the management of patients with lymphoma: Promise versus reality

【24h】

The role of biomarkers in the management of patients with lymphoma: Promise versus reality

机译：生物标志物在淋巴瘤患者管理中的作用：承诺与现实

获取原文

获取原文并翻译 | 示例

获取外文期刊封面目录资料

开具论文收录证明 >>

文献代查 >>

文献数据库（团队版） >>

页面导航

摘要
著录项
引文网络
相似文献
相关主题

摘要

In this issue of Clinical Lymphoma & Myeloma, two articles appearregarding prognostic biomarkers in lymphoma. Mitrovic and colleaguesdetail a single-institution retrospective study in which patientswith newly diagnosed diffuse large B-cell lymphoma (DLBCL) weretreated with cyclophosphamide, doxorubicin, vincristine, and prednisone(CHOP)–like regimens with or without rituximab.1

机译：在本期《临床淋巴瘤和骨髓瘤》中，有两篇文章涉及淋巴瘤的预后生物标志物。 Mitrovic及其同事进行了一项单机构回顾性研究，其中对患有新诊断的弥漫性大B细胞淋巴瘤（DLBCL）的患者接受环磷酰胺，阿霉素，长春新碱和泼尼松（CHOP）样治疗，伴或不伴利妥昔单抗治疗。1

著录项

来源
《Clinical lymphoma & myeloma》 |2009年第2期|共3页
作者
HsiE.;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类肿瘤学;
关键词

相似文献

外文文献
中文文献
专利

1. The role of biomarkers in the management of patients with lymphoma: Promise versus reality [J] . HsiE. Clinical lymphoma & myeloma . 2009,第2期

机译：生物标志物在淋巴瘤患者管理中的作用：承诺与现实
2. Comment on: 3 year follow-up comparing metabolic surgery versus medical weight management in patients with type 2 diabetes and BMI 30–35; the role of sRAGE biomarker as predictor of satisfactory outcomes [J] . Gordon G. Wisbach Surgery for obesity and related diseases: official journal of the American Society for Bariatric Surgery . 2016,第7期

机译：评论：3年后续比较2型糖尿病和BMI 30-35患者的代谢手术与医疗体重管理; SRAGE BIOMARKER作为令人满意的结果的预测因素的作用
3. Three-year follow-up comparing metabolic surgery versus medical weight management in patients with type 2 diabetes and BMI 30–35. The role of sRAGE biomarker as predictor of satisfactory outcomes [J] . Daniel Horwitz, John K. Saunders, Aku Ude-Welcome, Surgery for obesity and related diseases: official journal of the American Society for Bariatric Surgery . 2016,第7期

机译：三年随访比较2型糖尿病患者和BMI 30-35患者的代谢手术与医疗重量管理。 SRAGE BIOMARKER作为令人满意的结果的预测因素的作用
4. SHORE-BASED BIOMARKERS ALLOW PATIENT VERSUS CONTROL CLASSIFICATION IN STROKE [C] . S. Obertino, L. Brusini, I. Boscolo Galazzo, IEEE International Symposium on Biomedical Imaging . 2016

机译：岸上的生物标志物允许患者与中风中的控制分类
5. Prognostic Biomarkers for Diffuse Large B Cell Lymphoma Patient Survival after Treatment with Chemotherapy: A Retrospective Analysis of 88 Cases [D] . Bushra, Hamama tul. 2019

机译：弥漫性大B细胞淋巴瘤化疗后患者生存的预后生物标志物：88例回顾性分析
6. The role of extracorporeal photopheresis in the management of cutaneous T‐cell lymphoma graft‐versus‐host disease and organ transplant rejection: a consensus statement update from the UK Photopheresis Society [O] . Arun Alfred, Peter C. Taylor, Fiona Dignan, -1

机译：体外光采在皮肤T细胞淋巴瘤移植物抗宿主病和器官移植排斥反应中的作用：英国光采学会的共识声明更新
7. Randomized Pilot Trial of Bariatric Surgery Versus Intensive Medical Weight Management on Diabetes Remission in Type 2 Diabetic Patients Who Do NOT Meet NIH Criteria for Surgery and the Role of Soluble RAGE as a Novel Biomarker of Success [O] . Manish Parikh, Mimi Chung, Sheetal Sheth, 2014

机译：在2型糖尿病患者的糖尿病患者对糖尿病患者的糖尿病患者的随机试验试验与糖尿病患者的糖尿病患者进行了不符合NIH标准，以及作为一种成功的新型生物标志物的可溶性愤怒的作用
8. Information as a Weapon. Reality Versus Promises [R] . Whitehead, Y. G. 1999

机译：信息作为武器。现实与承诺

The role of biomarkers in the management of patients with lymphoma: Promise versus reality

摘要

著录项

引文网络

相似文献

相关主题

期刊订阅